Stanley W. Carson

1.9k citations

54 papers · 1.3k indexed · h-index 21

Impact in

Behavioral Neuroscience top 5%
- Stress Responses and Cortisol
Biological Psychiatry top 5%

Papers in

Behavioral Neuroscience 8
- Stress Responses and Cortisol 8
Biological Psychiatry 4

Co-authors: Michael Kotlyar June M. Fry Markus H. Schmidt Richard Bogan John S. Markowitz S. Craig Risch David W. Boulton Ziad Nahas
Journals: Biological Psychiatry (9 papers)The Journal of Clinical Pharmacology (4 papers)Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy (3 papers)Clinical Pharmacology & Therapeutics (3 papers)Journal of Clinical Psychopharmacology (3 papers)
Partner nations: United States United Kingdom Australia

In The Last Decade

Stanley W. Carson

49 papers receiving 1.2k citations

Peers

Countries citing papers authored by Stanley W. Carson

Since Specialization

Citations

This map shows the geographic impact of Stanley W. Carson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stanley W. Carson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stanley W. Carson more than expected).

Fields of papers citing papers by Stanley W. Carson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stanley W. Carson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stanley W. Carson. The network helps show where Stanley W. Carson may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Stanley W. Carson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Stanley W. Carson Line = papers co-authored together Stanley W. Carson links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	A STUDY OF THE EFFECTS OF INHIBITION OF CYP3A4 BY KETOCONAZOLE (K) AND CYP2C8 BY GEMFIBROZIL (G) ON THE PHARMACOKINETICS DABRAFENIB (D) Clinical Pharmacology & Therapeutics ·Benjamin Suttle, Kenneth F. Grossmann, 昭雄伊東, Danièle Ouellet, Gursel Aktan, BinBin LIU, Patricia LoRusso, Y. Wei, Shilpy Sharma, Kari Kendra, Christian Michel, Shubham Pant, Hendrik-Tobias Arkenau, Mark R. Middleton, Leyla Ates, Stanley W. Carson	2014	3
2	Assessment of the drug interaction potential and single‐ and repeat‐dose pharmacokinetics of the BRAF inhibitor dabrafenib The Journal of Clinical Pharmacology ·A. Benjamin Suttle, Kenneth F. Grossmann, Danièle Ouellet, 昭雄伊東, Gursel Aktan, Michael S. Gordon, Patricia LoRusso, Jeffrey R. Infante, Sunil Sharma, Kari Kendra, Manish R. Patel, Shubham Pant, Hendrik‐Tobias Arkenau, Mark R. Middleton, Samuel C. Blackman, Gennadiy Moskalyk, Stanley W. Carson	2014	41
3	Effects of particle size, food, and capsule shell composition on the oral bioavailability of dabrafenib, a BRAF inhibitor, in patients with BRAF mutation-positive tumors Journal of Pharmaceutical Sciences ·Danièle Ouellet, Kenneth F. Grossmann, Katrina Görög, Noelia Nebot, Kohtsuki, Abby Tallmer, Michael S. Gordon, Sunil Sharma, Jeffrey R. Infante, Patricia LoRusso, J Almecija, William E. Fehrenbach, Samuel C. Blackman, Stanley W. Carson	2013	40
4	Lack of a Fluoxetine Effect on Prednisolone Disposition and Cortisol Suppression Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy ·Stanley W. Carson, S. P. Vander Kloet, Michael Kotlyar, C. R. Markham, Manuel E. Tancer	2004	4
5	Effect of St. John's wort (Hypericum perforatum) on cytochrome P-450 2D6 and 3A4 activity in healthy volunteers Life Sciences ·John S. Markowitz, C. Lindsay DeVane, David W. Boulton, Stanley W. Carson, Ziad Nahas, S. Craig Risch	2000	114
6	Single-Dose Pharmacokinetics of Methylphenidate in CYP2D6 Extensive and Poor Metabolizers Journal of Clinical Psychopharmacology ·C. Lindsay DeVane, John S. Markowitz, Stanley W. Carson, David W. Boulton, Diego Andrés Rodríguez Lugo, Ziad Nahas, S. Craig Risch	2000	27
7	Evaluation of the Influence of Diabetes Mellitus on Antipyrine Metabolism and CYP1A2 and CYP2D6 Activity Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy ·Chaerunisa Utami, Reginald F. Frye, Sang Chon Kim, Robert J. Straka, Stanley W. Carson	2000	58
8	Effects of obesity on the cytochrome P450 enzyme system. PubMed ·Michael Kotlyar, Stanley W. Carson	1999	109
9	Intravenous clomipramine challenge in obsessive-compulsive disorder: predicting response to oral therapy at eight weeks Biological Psychiatry ·Floyd R. Sallee, (unknown), Stefano Pallanti, Stanley W. Carson, VICTOR GUEDES DE LIMA	1998	17
10	Parenteral clomipramine challenge in depressed adolescents: mood and neuroendocrine response Biological Psychiatry ·Floyd R. Sallee, Nandagopal Vrindavanam, Michael M Hayashi, Lorenzo Falcón López, Stanley W. Carson, Gopalan Sethuraman	1998	18
11	The effects of age, gender, and season on serotonergic function in healthy subjects Progress in Neuro-Psychopharmacology and Biological Psychiatry ·Robert N. Golden, Nafa Firliadhila, R. David Ekstrom, Bettina Knight, Cunhua Pan, Helen Miller, Stanley W. Carson	1996	13
12	Pharmacokinetics of Ondansetron in Patients with Hepatic Insufficiency The Journal of Clinical Pharmacology ·William D. Figg, George E. Dukes, J. Fred Pritchard, David Hermann, Henry R. Lesesne, Stanley W. Carson, Stephen Germic, J. Robert Powell, Lawrence J. Hak	1996	36
13	An Improved Micromethod for Vancomycin Determination by High-Performance Liquid Chromatography Therapeutic Drug Monitoring ·Li Li, Michael V. Miles, William R. Hall, Stanley W. Carson	1995	22
14	Lithium pharmacokinetics in the obese Clinical Pharmacology & Therapeutics ·R A Reiss, Curtis E. Haas, شهین احمدی, Barry M. Gumbiner, Stephen Welle, Stanley W. Carson	1994	37
15	The influence of type i and type ii diabetes mellitus on antipyrine disposition Clinical Pharmacology & Therapeutics ·Carlos E. Eduarte A., Reginald F. Frye, Stanley W. Carson, Victor Miguel Castillo de Macedo, Caio Mateus Caires Rangel	1992	2
16	CONFOUNDING VARIABLES IN NEUROENDOCRINE CHALLENGE TESTS: WHAT WE NEED TO CONTROL FOR Clinical Neuropharmacology ·Robert N. Golden, John H. Gilmore, R. David Ekstrom, Stephen T. Astley, Stanley W. Carson	1992	1
17	Effect of electroconvulsive therapy on serum concentration of alpha-1-acid glycoprotein Biological Psychiatry ·C. Lindsay DeVane, C. F. Lim, Stanley W. Carson, 載鳳林, L. Peter Hackett, Michael R. Ware	1991	2
18	Effect of Assay Methodology on the Prediction of Lithiumc Maintenance Dosage DICP ·شهین احمدی, Stanley W. Carson, Jeni Holden	1989	2
19	Altered plasma dexamethasone and cortisol suppressibility in patients with panic disorders Biological Psychiatry ·Stanley W. Carson, Uriel Halbreich, Keith H. Zook, 肖琪经	1988	10
20	Evaluation of a Two-Point Method for Prediction of Lithium Maintenance Dosage International Clinical Psychopharmacology ·شهین احمدی, Stanley W. Carson, Jeni Holden, Avinash Vikram	1987	3

About Stanley W. Carson

Stanley W. Carson is a scholar working on Behavioral Neuroscience, Biological Psychiatry, Pharmacology, Endocrinology, Diabetes and Metabolism and Psychiatry and Mental health, having authored 54 papers that have together received 1.3k indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (8 papers), Stress Responses and Cortisol (8 papers), Melanoma and MAPK Pathways (7 papers), Pharmaceutical studies and practices (7 papers), Treatment of Major Depression (6 papers), Analytical Methods in Pharmaceuticals (5 papers), Adrenal Hormones and Disorders (5 papers) and Synthesis and biological activity (4 papers). The work is most often cited by research in Behavioral Neuroscience (134 citations), Biological Psychiatry (75 citations), Pharmacology (223 citations), Pharmacology (181 citations) and Psychiatry and Mental health (159 citations). Stanley W. Carson has collaborated with scholars based in United States, United Kingdom and Australia. Frequent co-authors include Michael Kotlyar, June M. Fry, Markus H. Schmidt, Richard Bogan, John S. Markowitz, S. Craig Risch, David W. Boulton, Ziad Nahas, Robert N. Golden and C. Lindsay DeVane. Their work appears in journals such as Biological Psychiatry, The Journal of Clinical Pharmacology, Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy, Clinical Pharmacology & Therapeutics and Journal of Clinical Psychopharmacology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact